7Baggers
Quarterly
Annual
    Unit: USD2025-09-27 2025-06-28 2025-03-29 2024-12-28 2024-09-28 2024-06-29 2024-03-30 2023-09-30 2023-07-01 2023-04-01 2022-09-24 2022-06-25 2022-03-26 2021-09-25 2021-06-26 2021-03-27 2020-09-26 2020-06-27 2020-03-28 2019-09-28 2019-06-29 2019-03-30 2018-09-29 2018-06-30 2018-03-31 2017-09-30 2017-07-01 2017-04-01 2016-09-24 2016-06-25 2016-03-26 2015-09-26 2015-06-27 2015-03-28 2014-09-27 2014-06-28 2014-03-29 
      
    		                                     
      cash flows from operating activities:
    		                                     
      net earnings
    		75,542,000 100,871,000 79,423,000 69,783,000 101,619,000 126,232,000 121,099,000 134,183,000 150,788,000 125,578,000 172,101,000 207,853,000 193,131,000 125,747,000 175,360,000 104,251,000 78,861,000 69,694,000 40,570,000 52,581,000 55,145,000 36,002,000 42,066,000 45,132,000 33,582,000 34,668,000 34,575,000 21,634,000 28,764,000 34,238,000 20,255,000 26,883,000 26,884,000 10,804,000 20,492,000 22,447,000 7,668,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                     
      depreciation
    		34,633,000 34,000,000 32,941,000 32,511,000 31,487,000 30,624,000 30,019,000 27,646,000 27,012,000 25,774,000 24,847,000 22,192,000 21,842,000 23,399,000 19,609,000 18,733,000 15,896,000 15,613,000 15,717,000 15,452,000 14,725,000 14,475,000 14,346,000 13,432,000 12,712,000 12,762,000 11,856,000 11,392,000 9,836,000 9,686,000 9,492,000 9,607,000 9,410,000 8,996,000 8,597,000 7,953,000 7,691,000 
      amortization of intangibles
    		5,921,000 5,928,000 5,817,000 5,900,000 5,886,000 5,853,000 5,882,000 4,954,000 5,362,000 5,009,000 4,708,000 4,068,000 4,672,000 2,176,000 3,195,000 3,998,000 2,734,000 1,558,000 1,571,000 1,744,000 1,094,000 1,852,000 1,572,000 1,474,000 1,228,000 1,172,000 1,258,000 1,119,000 583,000 592,000 693,000 842,000 905,000 983,000 549,000 608,000 586,000 
      expense associated with share-based and grant compensation arrangements
    		7,536,000 8,809,000 11,561,000 10,818,000 8,069,000 7,999,000 11,277,000 8,193,000 8,238,000 9,637,000 7,437,000 5,611,000 6,931,000 2,702,000 2,761,000 2,981,000 849,000 859,000 1,444,000 896,000 922,000 1,287,000 838,000 830,000 1,094,000             
      deferred income taxes
    		-167,000 -209,000 -17,000 -14,708,000 -973,000 180,000 119,000 432,000 -77,000 -242,000 -448,000 78,000 101,000 -771,000 35,000 142,000 -180,000 4,000 286,000    -18,000 -46,000 -519,000 -238,000 131,000 224,000 -108,000   -272,000 196,000 -193,000 81,000 196,000 -150,000 
      unrealized gain on investments and other
    		-1,541,000 -1,326,000 672,000   305,000 -2,130,000    2,272,000 4,580,000 1,601,000                         
      equity in (earnings) loss of investee
    		-278,000                                     
      net income on sale, disposition and impairment of assets
    		58,000                                     
      impairment of goodwill and other intangibles
    		                                     
      gain from reduction of estimated earnout liability
    		0 -1,511,000 -344,000 -605,000 0                                 
      changes in:
    		                                     
      accounts receivable
    		79,591,000 27,305,000 -211,709,000 149,425,000 74,484,000 -12,226,000 -164,613,000 100,834,000 7,347,000 -191,064,000 167,108,000 48,213,000 -352,928,000 195,006,000 -82,771,000 -253,323,000 -55,684,000 -61,301,000 -94,253,000 11,627,000 -38,752,000 -100,716,000 34,599,000 -55,901,000 -99,765,000 -20,449,000 -33,473,000 -67,766,000 25,841,000 -30,922,000 -64,276,000 28,206,000 -41,781,000 -63,148,000 29,053,000 -43,870,000 -61,825,000 
      inventories
    		58,564,000 36,291,000 -33,830,000 -74,882,000 39,554,000 59,472,000 -17,788,000 76,146,000 139,739,000 14,674,000 98,394,000 123,366,000 -258,019,000 125,433,000 -121,809,000 -207,768,000 -65,150,000 51,766,000 -25,783,000 52,170,000 51,657,000 -23,649,000 22,380,000 -4,425,000 -57,403,000 26,159,000 34,005,000 -60,984,000 14,119,000 29,723,000 -22,159,000 41,262,000 74,228,000 -64,422,000 3,978,000 34,756,000 -23,980,000 
      accounts payable and cash overdraft
    		-26,644,000 -20,015,000 52,902,000 -14,997,000 -23,734,000 8,861,000 52,264,000 -7,806,000 -11,489,000 68,388,000 -67,367,000 -87,775,000 143,895,000 -89,581,000 21,126,000 121,892,000 28,337,000 36,970,000 20,047,000 -35,654,000 24,891,000 25,056,000 -24,054,000 22,730,000 39,935,000 15,278,000 5,377,000 32,769,000 3,706,000 9,822,000 21,498,000 -34,934,000 579,000 45,219,000 -22,265,000   
      accrued liabilities and other
    		50,369,000 28,785,000 -46,166,000 -23,537,000 23,944,000 27,567,000 -53,290,000 44,779,000 31,963,000 -95,105,000 32,803,000 5,153,000 -6,466,000 20,316,000 64,661,000 14,090,000 33,155,000 80,894,000 -8,648,000 27,089,000 17,258,000 -7,924,000 5,466,000 24,397,000 -8,502,000 12,154,000 31,743,000 -9,676,000 12,974,000 16,121,000 4,318,000 12,342,000 16,745,000 10,880,000 9,309,000 26,194,000 -2,743,000 
      net cash from operating activities
    		285,984,000 221,945,000 -108,807,000 144,909,000 258,584,000 255,876,000 -16,798,000 390,739,000 358,140,000 -37,076,000 442,649,000 335,428,000 -245,031,000 397,496,000 80,927,000 -196,660,000 37,873,000 193,371,000 -46,161,000 127,132,000 126,777,000 -55,829,000 96,173,000 48,100,000 -84,172,000 82,139,000 85,951,000 -70,740,000 96,336,000 69,998,000 -29,957,000 84,587,000 87,367,000 -50,545,000 47,724,000 77,536,000 -54,732,000 
      capex
    		-75,752,000 -62,484,000 -67,268,000 -66,781,000 -58,908,000 -57,437,000 -49,148,000 -45,966,000 -46,815,000 -38,166,000 -42,050,000 -39,603,000 -32,072,000 -31,064,000 -44,372,000 -34,656,000 -20,294,000 -19,444,000 -27,286,000 -23,861,000 -26,594,000 -15,883,000 -20,228,000 -29,951,000 -24,362,000 -22,640,000 -18,018,000 -16,531,000 -11,454,000 -11,328,000 -12,941,000 -8,764,000 -12,654,000 -15,102,000 -11,576,000 -11,106,000 -8,994,000 
      free cash flows
    		210,232,000 159,461,000 -176,075,000 78,128,000 199,676,000 198,439,000 -65,946,000 344,773,000 311,325,000 -75,242,000 400,599,000 295,825,000 -277,103,000 366,432,000 36,555,000 -231,316,000 17,579,000 173,927,000 -73,447,000 103,271,000 100,183,000 -71,712,000 75,945,000 18,149,000 -108,534,000 59,499,000 67,933,000 -87,271,000 84,882,000 58,670,000 -42,898,000 75,823,000 74,713,000 -65,647,000 36,148,000 66,430,000 -63,726,000 
      cash flows used in investing activities:
    		                                     
      purchases of property, plant and equipment
    		-75,752,000 -62,484,000 -67,268,000 -66,781,000 -58,908,000 -57,437,000 -49,148,000 -45,966,000 -46,815,000 -38,166,000 -42,050,000 -39,603,000 -32,072,000 -31,064,000 -44,372,000 -34,656,000 -20,294,000 -19,444,000 -27,286,000 -23,861,000 -26,594,000 -15,883,000 -20,228,000 -29,951,000 -24,362,000 -22,640,000 -18,018,000 -16,531,000 -11,454,000 -11,328,000 -12,941,000 -8,764,000 -12,654,000 -15,102,000 -11,576,000 -11,106,000 -8,994,000 
      proceeds from sale of property, plant and equipment
    		13,614,000 2,936,000 758,000 7,706,000 1,442,000 1,009,000 1,344,000 1,422,000 470,000 319,000 274,000 822,000 1,207,000 19,924,000 1,611,000 5,062,000 1,944,000 235,000 409,000 203,000 736,000 241,000 888,000 474,000 36,250,000 1,082,000 686,000 353,000 207,000 177,000 132,000 1,297,000 1,035,000 50,000 4,709,000 969,000 785,000 
      acquisitions and purchases of non-controlling interest, net of cash received
    		           -14,772,000 -24,571,000 -36,000 -172,106,000 -261,133,000 -16,131,000 -202,000 -18,487,000                   
      purchases of investments
    		-10,515,000 -9,682,000 -7,191,000 -21,113,000 -17,868,000 -7,064,000 -9,352,000 -11,586,000 -3,038,000 -11,709,000 -1,759,000 -9,136,000 -6,030,000 -3,285,000 -5,843,000 -8,738,000 -4,172,000 -6,042,000 -14,052,000 -1,616,000 -4,410,000 -449,000 -3,053,000 -2,630,000 -6,718,000 2,963,000 -14,299,000 -819,000 -897,000         
      proceeds from sale of investments
    		6,997,000 5,163,000 2,304,000 17,062,000 4,498,000 4,984,000 4,300,000 10,615,000 2,637,000 8,849,000 1,815,000 3,496,000 4,725,000 2,972,000 3,504,000 3,381,000 3,942,000 7,079,000 11,260,000 492,000 3,327,000 340,000 118,000 -1,865,000 5,045,000 -3,020,000 6,043,000 1,204,000 494,000         
      other
    		-56,000 2,009,000 -418,000 -306,000 12,386,000 -4,468,000 -3,206,000 -4,168,000 3,227,000 -1,151,000 3,740,000 166,000 -2,995,000 -2,770,000 -294,000 -414,000 -4,000 372,000 -54,000 209,000 -210,000 200,000 732,000 -758,000 -594,000 41,000 -267,000 142,000 -997,000 -563,000 -173,000 238,000 -42,000 -16,000 40,000 -99,000 -36,000 
      net cash from investing activities
    		-67,632,000 -74,029,000 -75,550,000 -93,262,000 -58,450,000 -62,976,000 -56,062,000 -102,238,000 -43,452,000 -41,858,000 -103,849,000 -59,027,000 -59,736,000 -14,259,000 -217,500,000 -296,498,000 -34,715,000 -18,002,000 -48,210,000 -58,249,000 -32,185,000 -15,551,000 -22,546,000 -64,373,000 1,304,000 -21,488,000 -29,288,000 -70,599,000 -170,776,000 -16,300,000 -13,386,000 -13,208,000 -13,457,000 -13,441,000 -5,674,000 -13,590,000 -14,425,000 
      cash flows used in financing activities:
    		                                     
      borrowings under revolving credit facilities
    		9,942,000 8,559,000 4,798,000 9,783,000 7,776,000 7,254,000 5,100,000 7,889,000 6,589,000 4,437,000 0 327,750,000 242,950,000 37,022,000 613,664,000 236,280,000 103,000 0 6,759,000 28,030,000 155,874,000 237,560,000 147,945,000 192,511,000 296,342,000 165,437,000 163,511,000 281,090,000 49,317,000 1,927,000 1,235,000 37,620,000 119,431,000 140,303,000 2,174,000 83,983,000 106,318,000 
      repayments under revolving credit facilities
    		-9,655,000 -8,062,000 -4,752,000 -11,779,000 -8,489,000 -7,710,000 -4,278,000 -10,060,000 -7,351,000 -4,518,000 0 -429,637,000 -141,438,000 -298,640,000 -468,125,000 -121,570,000 0 0 -6,498,000 -52,510,000 -234,795,000 -173,232,000 -237,284,000 -252,228,000 -179,429,000 -224,518,000 -211,544,000 -137,767,000 -23,967,000 -1,715,000 -1,495,000 -75,260,000 -183,275,000 -52,718,000 -12,568,000 -132,360,000 -47,547,000 
      repayment of debt on behalf of investee
    		   0 0 0 -6,303,000                               
      contingent consideration payments and other
    		0 0 -221,000 -89,000 0 -1,000,000 -3,779,000 0 0 -6,179,000 -11,000 -2,002,000 -551,000 -1,200,000 -837,000 -627,000                      
      proceeds from issuance of common stock
    		573,000 644,000 650,000 689,000 652,000 816,000 654,000 639,000 763,000 685,000 653,000 794,000 663,000 583,000 573,000 363,000 345,000 378,000 319,000 270,000 281,000 261,000 256,000 294,000 206,000 145,000 185,000 146,000 106,000 160,000 130,000 236,000 255,000 469,000 96,000 102,000 99,000 
      dividends paid to shareholders
    		-20,512,000 -20,656,000 -21,322,000 -20,061,000 -20,061,000 -20,249,000 -20,411,000 -18,574,000 -15,507,000 -15,642,000 -15,405,000 -15,474,000 -12,541,000 -9,281,000 -9,276,000 -9,274,000 -7,646,000 -7,644,000 -7,730,000 1,000   0   0   0   0   0   
      distributions to noncontrolling interest
    		-995,000   0 -2,448,000 -6,069,000 -3,331,000 -2,496,000 0 -4,859,000 -9,970,000 0 -2,053,000 0 0 -2,914,000 -633,000 0 -299,000 -734,000 -400,000 -500,000 -1,161,000 -303,000 -775,000 -1,319,000 -280,000 -1,673,000 -1,429,000 -561,000 -1,170,000 -1,909,000 -311,000 -939,000 -609,000 -400,000 -701,000 
      purchase of remaining noncontrolling interest of subsidiary
    		   0                         0         
      payments to taxing authorities in connection with shares directly withheld from employees
    		-22,000 -13,000 -9,547,000 0 0 0 -17,838,000                               
      repurchase of common stock
    		-29,054,000 -191,380,000 -60,553,000 2,000 -21,760,000 -100,564,000 -18,798,000 -6,592,000 -22,196,000 -33,288,000 -2,410,000 -90,304,000 -501,000    0 0 -29,212,000    -24,000 -971,000 -848,000 -3,042,000 -9,851,000 -83,000    -723,000 1,000 -78,000    
      net cash from financing activities
    		-49,707,000 -211,412,000 -90,926,000 -61,437,000 -49,215,000 -127,500,000 -68,968,000 -29,177,000     86,330,000 -271,519,000 135,999,000 101,927,000 142,150,000 -7,249,000 -39,723,000 -24,968,000 -91,324,000 61,069,000 -91,038,000 3,270,000 111,570,000 -63,291,000 -67,176,000 141,697,000    -40,038,000 -71,916,000 87,028,000 -15,679,000 -52,890,000 58,161,000 
      effect of exchange rate changes on cash
    		58,000 1,864,000 312,000 -2,184,000 -1,453,000 -3,805,000 79,000 -1,380,000 1,840,000 2,739,000 -1,095,000 -770,000 1,726,000 -404,000 461,000 -349,000 300,000 297,000 -1,719,000 -209,000 118,000 248,000 503,000 -489,000 233,000 59,000 314,000 882,000 -408,000 -518,000 -43,000 -724,000 -126,000 -154,000 -187,000 16,000 -76,000 
      net change in cash and cash equivalents
    		168,703,000 -61,632,000 -274,971,000 -11,974,000 149,466,000 61,595,000 -141,749,000 257,944,000 278,849,000 -135,563,000 311,064,000 64,288,000 -216,711,000 111,314,000 -113,000 -391,580,000 145,608,000 168,417,000 -135,813,000 43,706,000 3,386,000 -10,063,000 -16,908,000 -13,492,000 28,935,000 -2,581,000 -10,199,000 1,240,000 -50,834,000 44,452,000 -44,691,000 30,617,000 1,868,000 22,888,000   -11,072,000 
      cash, cash equivalents, and restricted cash, beginning of year
    		0 0 1,179,594,000 0 0 0 1,122,256,000 0 0 559,623,000 0 0 291,223,000 0 0 436,608,000 0 0 168,666,000 0 0 28,198,000 0 0 28,816,000 0 0 34,489,000          
      cash, cash equivalents, and restricted cash, end of period
    		168,703,000 -61,632,000 904,623,000 -11,974,000 149,466,000 61,595,000 980,507,000 257,944,000 278,849,000 424,060,000 311,064,000 64,288,000 74,512,000 111,314,000 -113,000 45,028,000 145,608,000 168,417,000 32,853,000 43,706,000 3,386,000 18,135,000 -16,908,000 -13,492,000 57,751,000 -2,581,000 -10,199,000 35,729,000          
      reconciliation of cash and cash equivalents and restricted cash:
    		                                     
      cash and cash equivalents, beginning of period
    		0 0 1,171,828,000 0 0 0 1,118,329,000 0 0 559,397,000 0 0 286,662,000 0 0 436,507,000 0 0 168,336,000 0 0 27,316,000 0 0 28,339,000 0 0 34,091,000          
      restricted cash, beginning of period
    		0 0 7,766,000 0 0 0 3,927,000 0 0 226,000 0 0 4,561,000 0 0 101,000 0 0 330,000 0 0 882,000 0 0 477,000 0 0 398,000          
      cash, cash equivalents, and restricted cash, beginning of period
    		0 0 1,179,594,000 0 0 0 1,122,256,000 0 0 559,623,000 0 0 291,223,000 0 0 436,608,000 0 0 168,666,000 0 0 28,198,000 0 0 28,816,000 0 0 34,489,000          
      cash and cash equivalents, end of period
    		166,702,000 -61,632,000 903,562,000 -18,979,000 149,466,000 61,595,000 979,746,000 254,944,000 278,849,000 423,299,000 311,064,000 64,288,000 73,783,000 94,351,000 -113,000 44,399,000 145,608,000 168,417,000 32,129,000 44,001,000 3,386,000 17,111,000 -1,174,000 2,175,000 25,326,000 -2,581,000 -6,395,000 31,020,000 -50,834,000 44,452,000 43,065,000 30,617,000 1,868,000 22,888,000    
      restricted cash, end of period
    		2,001,000 0 1,061,000 7,005,000 0 0 761,000 3,000,000 0 761,000 0 0 729,000 16,963,000 0 629,000 0 0 724,000 -295,000 0 1,024,000 -15,734,000 -15,667,000 32,425,000 0 -3,804,000 4,709,000          
      supplemental information:
    		                                     
      interest paid
    		3,111,000 2,352,000 3,038,000 3,521,000 2,924,000 3,218,000 3,099,000 3,147,000 3,036,000 3,309,000 2,989,000 4,112,000 2,896,000 3,253,000 4,413,000 2,694,000 319,000 3,419,000 374,000 629,000 4,088,000 570,000 1,066,000 3,046,000 843,000 861,000 2,552,000 497,000 367,000 1,865,000 355,000 404,000 2,056,000 374,000 320,000 1,874,000 281,000 
      income taxes paid
    		4,443,000 51,084,000 2,496,000 15,844,000 46,699,000 63,794,000 1,778,000 52,074,000 62,191,000 4,138,000 74,697,000 136,720,000 1,700,000 63,719,000 72,925,000 249,000 45,523,000 -529,000 2,307,000 18,537,000 11,768,000 2,801,000 19,930,000 17,500,000 1,245,000 18,213,000 13,558,000 2,337,000 23,595,000   23,929,000 11,084,000 -9,709,000 20,073,000 4,851,000 1,681,000 
      non-cash investing activities:
    		                                     
      capital expenditures included in accounts payable
    		198,000 -445,000 1,770,000 1,926,000 -1,446,000 -346,000 3,351,000 1,512,000 -1,207,000 3,122,000 355,000 344,000 2,512,000                         
      non-cash financing activities:
    		                                     
      common stock issued under deferred compensation plans
    		1,065,000 1,085,000 8,823,000 1,067,000 1,110,000 1,127,000 8,616,000 1,008,000 979,000 7,950,000 861,000 858,000 6,705,000 714,000 705,000 5,359,000 657,000 638,000 4,900,000 579,000 584,000 4,457,000 533,000 542,000 4,237,000 442,000 438,000 3,793,000 282,000 420,000 2,955,000 314,000 202,000 2,526,000 148,000 228,000 1,894,000 
      acquisitions, net of cash received and purchase of equity method investment
    		 -11,971,000 -3,735,000     -52,555,000                              
      cash flows used in operating activities:
    		                                     
      equity in loss of investee
    		  19,000  77,000 642,000 594,000 8,000 417,000 588,000                            
      net gain on sale, disposition and impairment of assets
    		  -76,000 -860,000 -453,000                                 
      unrealized (gain) loss on investments and other
    		   1,984,000     -1,142,000 -149,000     -1,030,000 -1,754,000                      
      repayments of debt
    		       0 0 -29,000 528,000 -2,286,000 -199,000                         
      net gain on sale and disposition of assets
    		      -231,000   -164,000 -414,000 1,072,000 -306,000 -8,905,000                        
      ​
    		                                     
      non-cash investing activities
    		                                     
      unrealized loss on investments and other
    		                                     
      net (gain) loss on sale and disposition of assets
    		       -283,000                              
      cash flows (used in) from financing activities:
    		                                     
      net cash (used in) from financing activities
    		         -59,368,000                    -8,728,000 -1,305,000       
      cash flows from (used in) operating activities:
    		                                     
      equity in earnings of investee
    		           1,017,000 515,000 946,000 835,000 630,000          1,000   -49,000 -111,000 -81,000 -88,000 -112,000 -83,000 -117,000 -78,000 -51,000 
      cash flows from investing activities:
    		                                     
      cash flows from financing activities:
    		                                     
      issuance of long-term debt
    		                      0               
      net gain on disposition of assets
    		               -532,000     -199,000 -122,000  477,000 -6,534,000             
      unrealized gain on investments
    		                -554,000   -93,000 -170,000 -1,348,000                
      net (gain) loss on disposition of assets and impairment of assets
    		                                     
      contingent consideration payment and other
    		                                     
      net gain on disposition of assets and impairment of assets
    		                 14,000 -285,000                   
      repayment of debt
    		                 -3,000 -3,074,000 -38,000 -32,000 -3,029,000 -74,000 -205,000 -5,232,000             
      unrealized (gain) loss on investments
    		                  3,173,000                   
      investment in life insurance contracts
    		                                     
      deferred income taxes credits
    		                   169,000 206,000 -742,000                
      acquisitions, net of cash received
    		                   -33,676,000   -1,003,000 -29,173,000 -8,787,000 -201,000   -64,933,000   0 1,000 -2,585,000 0 -2,944,000 -4,191,000 
      borrowings of debt
    		                      -712,000 263,000 1,376,000             
      net (gain) on disposition of assets and impairment of assets
    		                                     
      advances of notes receivable
    		                        -12,000 -6,000 0 -228,000 -2,454,000 -1,687,000 -1,259,000 -1,320,000 -1,810,000 -1,273,000 1,058,000 -825,000 -2,462,000 
      collections on notes receivable
    		                        482,000 293,000 320,000 721,000 2,088,000 2,323,000 1,408,000 1,725,000 1,269,000 5,790,000 95,000 415,000 473,000 
      expense associated with share-based compensation arrangements
    		                         696,000 711,000 571,000 591,000 545,000 432,000 477,000 496,000 378,000 513,000 437,000 495,000 
      expense associated with stock grant plans
    		                         45,000 53,000 46,000 35,000 33,000 37,000 32,000 26,000 27,000 23,000 29,000 29,000 
      net (gain) loss on disposition and impairment of assets
    		                              -10,000       
      repayments of debt of acquiree
    		                                     
      purchase of remaining noncontrolling interest, net of cash received
    		                                     
      cash contributed from noncontrolling interest
    		                         0            
      net income on disposition and impairment of assets
    		                          -264,000 -64,000          
      acquisitions and purchase of noncontrolling interest, net of cash received
    		                           -55,441,000          
      excess tax benefits from share-based compensation arrangements
    		                               0      
      cash restricted as to use
    		                            0 230,000 -553,000 -429,000 0 -305,000    
      cash and cash equivalents, beginning of year
    		                            0 0 87,756,000      -1,079,000 
      notes receivable exchanged for property
    		                               0 0 389,000    
      property exchanged for notes receivable
    		                                     
      acquisition earnout adjustment prior to final purchase accounting
    		                                     
      net gain on disposition and impairment of assets
    		                               230,000      
      deferred income tax credit
    		                              -156,000       
      income taxes refunded
    		                              -4,080,000       
      purchase of remaining noncontrolling interest in subsidiary
    		                               0      
      debt issuance costs
    		                               -2,000 0 -9,000 -2,000   
      other receivables exchanged for notes receivable
    		                                  0 0 2,768,000 
      adjustments to reconcile net earnings attributable to controlling interest:
    		                                     
      net (gain) loss on sale of impairment of property, plant and equipment
    		                                 14,000    
      net gain on sale of property, plant and equipment
    		                                   -329,000 -602,000 
      accounts payable
    		                                    18,150,000 
      cash (cash overdraft), end of period
    		                                    -12,151,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.